Table 1.
Cell Type | Epigenetic Player | Experimental Model | Effect | References |
---|---|---|---|---|
RGCs
(Retinal ganglion cells) |
TET1-dependent deletion of PTEN | Optic nerve crush model | Optic nerve regeneration | [94] |
Class I HDACs and HDAC 2 & 3 upregulation and HDAC3 nuclear localization in RGCs | Optic nerve crush model | Optic nerve degeneration/RGC apoptosis | [64] | |
Increased G9a expression and H3K9Me2 activity in the retina (RGC) and optic nerve | Traumatic brain injury (TBI) model | TBI causes apoptosis and oxidative stress in the retina (RGC) and optic nerve | [80] | |
Inhibition of retinal HDAC activity (post valproic acid treatment) |
|
Neuroprotection and histone hyperacetylation | [73,74] | |
Inhibition of HDAC3 activity (RGFP966 activity) | Optic nerve crush model | RGC survival and repression of the apoptotic gene in RGCs post optic nerve injury | [24,64] | |
Double knock out of HDAC1&2 | Optic nerve axotomy | Anti-apoptosis and neuroprotection effect | [68] | |
3-deazaneplanocin (DZNep) inhibits Ezh2 inhibition using 3-deazaneplanocin (DZNep) -reduces the trimethylation of histone 3 lysine 27 (H3K27me3) or activity | Retinal/RGC damage caused by intravitreal injection of N-methyl-D-aspartate (NMDA) | Prevent cell death and inner nuclear layer thinning induced by NMDA and improved visual function | [84] | |
Increased Histone H3K9 acetylation using Trichostatin A (TSA) | Lead-induced neurotoxicity | Promotes neurite outgrowth and branching, neuroprotection, neuronal differentiation, and neurite branching | [95] | |
Intravitreal JQ1 (BET inhibitor) administration | RGC damage induced by NMDA excitotoxicity | Sustained RGC number and gene expression and decreased TUNEL-positive cells in the ganglion cell layer | [48] | |
Promotion of p38 MAPKc activity and intravitreal administration of tranylcypromine (lysine-specific demethylase 1 (LSD1) inhibitor) | NMDA-induced excitotoxicity | Enhanced RGC survival | [85] | |
OSK-mediated vision restoration is TET1/2 dependent ectopic expression of Oct4 (also known as Pou5f1), Sox2, and Klf4 genes (OSK) in RGC | Optic nerve crush model | Axon regeneration | [12] | |
OPCs
(Oligodendrocyte progenitor cells) |
Increased levels of H3K27me3 from NSCs (neural stem cells) to immature OL and significantly decreased levels of histone acetylation (i.e., H3K9ac) at the early stages of OPC differentiation associated with increasing levels of H3K9me3 during OPC maturation | Human pluripotent stem cell culture | Differentiation of OPCs into OLs | [96] |
DNMT1 downregulation in oligodendrocytes |
|
|
[38,39] | |
Myelin | Downregulation of TET1 |
|
|
[32] |
|
[97] |
Disclaimer: All illustrations were created using Biorender (biorender.com).